Page last updated: 2024-09-04

atrasentan and Chronic Illness

atrasentan has been researched along with Chronic Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demirakca, S; Dieckmann, R; Gebhard, MM; Gorenflo, M; Hagl, S; Herpel, E; Klimpel, H; Neumayer, S; Ullmann, MV1
Chancellor, MB; Chermansky, CJ; Hiragata, S; Nelson, JB; Nishizawa, O; Ogawa, T; Pflug, BR; Sasatomi, K; Seki, S; Yoshimura, N1

Other Studies

2 other study(ies) available for atrasentan and Chronic Illness

ArticleYear
Atrasentan treatment of pulmonary vascular disease in piglets with increased pulmonary blood flow.
    Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:3

    Topics: Animals; Atrasentan; Blood Pressure; Cardiac Output; Chronic Disease; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Hypertension, Pulmonary; Hypertrophy; Immunohistochemistry; Lung; Pulmonary Artery; Pulmonary Circulation; Pyrrolidines; Random Allocation; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine; Vascular Endothelial Growth Factor A

2007
Therapeutic effects of endothelin-A receptor antagonist on bladder overactivity in rats with chronic spinal cord injury.
    Urology, 2008, Volume: 71, Issue:2

    Topics: Animals; Atrasentan; Chronic Disease; Endothelin A Receptor Antagonists; Female; Pyrrolidines; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Urinary Bladder, Overactive

2008